NEW YORK (GenomeWeb) – In a filing with the US Securities and Exchange Commission this week, Alere said that mediation between itself and Abbott Laboratories has concluded without resolution. 

Alere sued Abbott in August in a move designed to push its potential acquirer to fulfill its obligations under the terms of their merger agreement, and act promptly in obtaining the required anti-trust approvals.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.